It Takes a Recession to Slow U.S. Health Care Cost Increases

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

It takes a recession to slow what has normally been runaway U.S. health care costs. The trend may be part of a road map to keep costs down. These costs have risen at close to double digits in some years over the past decade. The Centers for Medicare and Medicaid Services reported that the same costs rose at a rate of only 3.9% in 2010. The agency said it was the most modest increase in the 51 years for which data has been kept.

The news was not as good as it may sound. CMS research showed that:

As such in 2010, the health spending share of the overall economy was unchanged at 17.9 percent. In the past, this share has increased, rising over time from 5.2 percent in 1960.

But, based on the past, the trend is good news.

The primary causes of past increases in health care expenditures were sharp increases in drug costs, the cost of hospital stays and doctor compensation. The government already has shown that, by regulating rises in Medicare reimbursements, private insurance companies use the trend as an excuse to lower their reimbursements. Doctors receive less, and usually then charge less for services. Physicians have argued that this has caused them to struggle financially and that patient care has suffered. But the reduction in compensation may encourage a new wave of physicians who are trained to treat more people for less remuneration.

Hospital costs are driven to a some extent by the number of days people spend in these facilities. Patients with incomes hurt by the recession probably cut the time they stayed in hospitals. There is no sign that this trend has hurt results. That is an indication that regulated length of days in hospitals may work to bring down costs.

The government also has approached the cost of drugs as a major target for price reductions. This is married with private sector activity. Availability of generics have brought down costs. Large retailers like Walmart (NYSE: WMT) have dropped the price they charge for prescription drugs.

CMS did not indicate that its leaders were concerned that health care results were hurt by the low 3.9% growth in health care expenditures. If that is so, there is a strong argument that any effort to maintain this slowing pace is a reasonable goal.

Douglas A. McIntyre

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618